Please wait while the formulary information is being retrieved.
Drug overview for LILETTA (levonorgestrel):
Generic name: LEVONORGESTREL (LEE-voe-nor-JES-trel)
Drug class: Contraceptives
Therapeutic class: Contraceptives
No enhanced Introduction information available for this drug.
No enhanced Uses information available for this drug.
Generic name: LEVONORGESTREL (LEE-voe-nor-JES-trel)
Drug class: Contraceptives
Therapeutic class: Contraceptives
No enhanced Introduction information available for this drug.
No enhanced Uses information available for this drug.
DRUG IMAGES
No Image Available
The following indications for LILETTA (levonorgestrel) have been approved by the FDA:
Indications:
Menorrhagia
Pregnancy contraception
Professional Synonyms:
Abnormally heavy menses
Contraception
Hypermenorrhea
Profuse vaginal menses bleeding
Indications:
Menorrhagia
Pregnancy contraception
Professional Synonyms:
Abnormally heavy menses
Contraception
Hypermenorrhea
Profuse vaginal menses bleeding
The following dosing information is available for LILETTA (levonorgestrel):
No enhanced Dosing information available for this drug.
No enhanced Administration information available for this drug.
No dosing information available.
No generic dosing information available.
The following drug interaction information is available for LILETTA (levonorgestrel):
There are 0 contraindications.
There are 0 severe interactions.
There are 0 moderate interactions.
The following contraindication information is available for LILETTA (levonorgestrel):
Drug contraindication overview.
No enhanced Contraindications information available for this drug.
No enhanced Contraindications information available for this drug.
There are 10 contraindications.
Absolute contraindication.
| Contraindication List |
|---|
| Abortion with sepsis |
| Carcinoma of breast |
| Carcinoma of cervix |
| Congenital abnormality of uterus |
| Endometrial carcinoma |
| Inflammatory disease of female pelvic organs |
| Malignant neoplasm of the uterus |
| Postpartum sepsis |
| Pregnancy |
| Uterine perforation by intrauterine contraceptive device |
There are 6 severe contraindications.
Adequate patient monitoring is recommended for safer drug use.
| Severe List |
|---|
| Abnormal vaginal bleeding |
| Acute myocardial infarction |
| Cervicitis |
| Coronary artery disease |
| Malignant neoplasm of liver |
| Puerperal endometritis |
There are 1 moderate contraindications.
Clinically significant contraindication, where the condition can be managed or treated before the drug may be given safely.
| Moderate List |
|---|
| Increased risk of bleeding due to coagulation disorder |
The following adverse reaction information is available for LILETTA (levonorgestrel):
Adverse reaction overview.
No enhanced Common Adverse Effects information available for this drug.
No enhanced Common Adverse Effects information available for this drug.
There are 25 severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
|
Abnormal vaginal bleeding Amenorrhea Menorrhagia |
Anemia Depression Ovarian enlargement |
| Rare/Very Rare |
|---|
|
Actinomycosis Angioedema Arterial thrombosis Bacterial sepsis Carcinoma of breast Cerebrovascular accident Deep venous thrombosis Ectopic pregnancy Endometritis Expulsion of intrauterine contraceptive device Hypersensitivity drug reaction Hypertension Inflammatory disease of female pelvic organs Migraine Pulmonary thromboembolism Septicemia due to streptococcus group A Streptococcal pelvic inflammatory disease Uterine perforation by intrauterine contraceptive device Venous thrombosis |
There are 34 less severe adverse reactions.
| More Frequent | Less Frequent |
|---|---|
|
Acne vulgaris Bacterial vaginosis Nausea Vomiting Vulvovaginal candidiasis Vulvovaginitis |
Acute abdominal pain Alopecia Back pain Cervicitis Drug-induced hot flash Dysmenorrhea Eczema Headache disorder Hirsutism Libido changes Mastalgia Mood changes Nervousness Oligomenorrhea Ovarian cyst Pelvic pain Pruritus of skin Skin rash Vaginal discharge Weight gain |
| Rare/Very Rare |
|---|
|
Abdominal distension Dizziness Dyspareunia Edema Lactation deficiency Skin pigmentation enhancement Urticaria Uterine cramps |
The following precautions are available for LILETTA (levonorgestrel):
No enhanced Pediatric Use information available for this drug.
Contraindicated
Severe Precaution
Management or Monitoring Precaution
Contraindicated
| None |
Severe Precaution
| None |
Management or Monitoring Precaution
| None |
No enhanced Pregnancy information available for this drug.
No enhanced Lactation information available for this drug.
No enhanced Geriatric Use information available for this drug.
The following prioritized warning is available for LILETTA (levonorgestrel):
No warning message for this drug.
No warning message for this drug.
The following icd codes are available for LILETTA (levonorgestrel)'s list of indications:
| Menorrhagia | |
| N92.0 | Excessive and frequent menstruation with regular cycle |
| N92.1 | Excessive and frequent menstruation with irregular cycle |
| N92.2 | Excessive menstruation at puberty |
| N92.4 | Excessive bleeding in the premenopausal period |
| N92.5 | Other specified irregular menstruation |
| N92.6 | Irregular menstruation, unspecified |
| N93.8 | Other specified abnormal uterine and vaginal bleeding |
| N93.9 | Abnormal uterine and vaginal bleeding, unspecified |
| Pregnancy contraception | |
| Z30 | Encounter for contraceptive management |
| Z30.01 | Encounter for initial prescription of contraceptives |
| Z30.011 | Encounter for initial prescription of contraceptive pills |
| Z30.013 | Encounter for initial prescription of injectable contraceptive |
| Z30.014 | Encounter for initial prescription of intrauterine contraceptive device |
| Z30.015 | Encounter for initial prescription of vaginal ring hormonal contraceptive |
| Z30.016 | Encounter for initial prescription of transdermal patch hormonal contraceptive device |
| Z30.017 | Encounter for initial prescription of implantable subdermal contraceptive |
| Z30.018 | Encounter for initial prescription of other contraceptives |
| Z30.019 | Encounter for initial prescription of contraceptives, unspecified |
| Z30.4 | Encounter for surveillance of contraceptives |
| Z30.40 | Encounter for surveillance of contraceptives, unspecified |
| Z30.41 | Encounter for surveillance of contraceptive pills |
| Z30.42 | Encounter for surveillance of injectable contraceptive |
| Z30.43 | Encounter for surveillance of intrauterine contraceptive device |
| Z30.430 | Encounter for insertion of intrauterine contraceptive device |
| Z30.431 | Encounter for routine checking of intrauterine contraceptive device |
| Z30.433 | Encounter for removal and reinsertion of intrauterine contraceptive device |
| Z30.44 | Encounter for surveillance of vaginal ring hormonal contraceptive device |
| Z30.45 | Encounter for surveillance of transdermal patch hormonal contraceptive device |
| Z30.46 | Encounter for surveillance of implantable subdermal contraceptive |
| Z30.49 | Encounter for surveillance of other contraceptives |
| Z30.8 | Encounter for other contraceptive management |
| Z30.9 | Encounter for contraceptive management, unspecified |
| Z79.3 | Long term (current) use of hormonal contraceptives |
| Z97.5 | Presence of (intrauterine) contraceptive device |
Formulary Reference Tool